Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05908 | 33079307 | Arch Pharm Res | Emerging roles of ferroptosis in liver pathophysiology. | 2020 | Details |
| A05909 | 33078906 | FASEB J | Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism. | 2020 | Details |
| A05910 | 33078654 | Autophagy | Mir214-3p and Hnf4a/Hnf4α reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis. | 2020 | Details |
| A05911 | 33078424 | J Food Biochem | Role of potato protein hydrolysate and exercise in preventing high-fat diet-induced hepatocyte apoptosis in senescence-accelerated mouse. | 2020 | Details |
| A05912 | 33078254 | Clin Rheumatol | Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study. | 2020 | Details |
| A05914 | 33077425 | Drug Metab Dispos | Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis. | 2020 | Details |
| A05916 | 33076582 | Life (Basel) | Quercitrin Ameliorates Hyperlipidemia and Hepatic Steatosis in Ovariectomized Mice. | 2020 | Details |
| A05917 | 33076386 | Biomolecules | Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD. | 2020 | Details |
| A05918 | 33076344 | Biology (Basel) | The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD. | 2020 | Details |
| A05919 | 33076261 | Antioxidants (Basel) | Western Diet Causes Obesity-Induced Nonalcoholic Fatty Liver Disease Development by Differentially Compromising the Autophagic Response. | 2020 | Details |
| A05920 | 33075820 | J Clin Endocrinol Metab | Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood. | 2021 | Details |
| A05921 | 33075563 | Cell Mol Gastroenterol Hepatol | S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis. | 2020 | Details |
| A05922 | 33075553 | Clin Gastroenterol Hepatol | Dynamic Positron Emission Tomography/Computed Tomography Imaging Correlate of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05923 | 33075504 | Diabetes Metab | Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study. | 2020 | Details |
| A05924 | 33074035 | Expert Opin Investig Drugs | The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success. | 2020 | Details |
| A05925 | 33073962 | Clin Lab | Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population. | 2020 | Details |
| A05926 | 33073046 | Transl Gastroenterol Hepatol | Approach to prevention of non-alcoholic fatty liver disease after liver transplantation. | 2020 | Details |
| A05927 | 33073044 | Transl Gastroenterol Hepatol | Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease. | 2020 | Details |
| A05928 | 33072790 | Front Med (Lausanne) | Roles of Macrophages and Exosomes in Liver Diseases. | 2020 | Details |
| A05929 | 33072754 | Front Cell Dev Biol | Role of Mitofusins and Mitophagy in Life or Death Decisions. | 2020 | Details |
| A05930 | 33072533 | Adv Pharm Bull | The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. | 2020 | Details |
| A05931 | 33072455 | Cureus | Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2020 | Details |
| A05932 | 33072167 | Nutr Metab (Lond) | Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme. | 2020 | Details |
| A05933 | 33071981 | Front Endocrinol (Lausanne) | Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function. | 2020 | Details |
| A05934 | 33071979 | Front Endocrinol (Lausanne) | Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. | 2020 | Details |
| A05935 | 33071964 | Front Endocrinol (Lausanne) | Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity. | 2020 | Details |
| A05936 | 33071788 | Front Pharmacol | Veratrilla baillonii Franch Could Alleviate Lipid Accumulation in LO2 Cells by Regulating Oxidative, Inflammatory, and Lipid Metabolic Signaling Pathways. | 2020 | Details |
| A05937 | 33070506 | J Prev Med Public Health | Relationship Between Non-alcoholic Fatty Liver Disease and Decreased Bone Mineral Density: A Retrospective Cohort Study in Korea. | 2020 | Details |
| A05938 | 33070425 | Int J Clin Pract | Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. | 2020 | Details |
| A05939 | 33070312 | FEBS Lett | Comprehensive analysis of circular RNAs from steatotic livers after ischemia and reperfusion injury by next-generation RNA sequencing. | 2020 | Details |
| A05940 | 33069975 | Comput Methods Programs Biomed | Combined methods of optical spectroscopy and artificial intelligence in the assessment of experimentally induced non-alcoholic fatty liver. | 2020 | Details |
| A05941 | 33069882 | Clin Gastroenterol Hepatol | Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. | 2020 | Details |
| A05942 | 33068638 | J Hepatol | Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. | 2020 | Details |
| A05944 | 33067796 | J Endocrinol Invest | Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome. | 2020 | Details |
| A05945 | 33067612 | Bioinformatics | A novel estimator of the interaction matrix in Graphical Gaussian Model of omics data using the entropy of non-equilibrium systems. | 2021 | Details |
| A05946 | 33067533 | Sci Rep | HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse. | 2020 | Details |
| A05947 | 33066497 | J Pers Med | Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development. | 2020 | Details |
| A05948 | 33066325 | Cancers (Basel) | Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma. | 2020 | Details |
| A05949 | 33066113 | Int J Mol Sci | Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis. | 2020 | Details |
| A05950 | 33065985 | Nutrients | Genomics in Personalized Nutrition: Can You "Eat for Your Genes"? | 2020 | Details |
| A05951 | 33065588 | Am J Gastroenterol | Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus. | 2021 | Details |
| A05952 | 33064664 | Endocr Connect | The hepatic lipidome and HNF4α and SHBG expression in human liver. | 2020 | Details |
| A05953 | 33064150 | J Clin Endocrinol Metab | The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. | 2021 | Details |
| A05954 | 33063664 | Elife | Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver. | 2020 | Details |
| A05955 | 33062150 | Oxid Med Cell Longev | Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c. | 2020 | Details |
| A05956 | 33061886 | Food Nutr Res | Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver disease. | 2020 | Details |
| A05957 | 33061798 | Int J Biol Sci | Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma. | 2020 | Details |
| A05958 | 33061754 | Turk Pediatri Ars | The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity. | 2020 | Details |
| A05959 | 33061687 | Hepat Med | Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A05960 | 33061293 | Drug Des Devel Ther | Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice. | 2020 | Details |
| A05961 | 33060775 | Sci Rep | Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease. | 2020 | Details |
| A05962 | 33060605 | Sci Rep | Clusterin overexpression protects against western diet-induced obesity and NAFLD. | 2020 | Details |
| A05963 | 33060460 | Curr Opin Clin Nutr Metab Care | Protein and amino acids in nonalcoholic fatty liver disease. | 2021 | Details |
| A05964 | 33060043 | Dig Liver Dis | Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. | 2020 | Details |
| A05965 | 33059586 | BMC Gastroenterol | The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study. | 2020 | Details |
| A05966 | 33059584 | BMC Gastroenterol | Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF). | 2020 | Details |
| A05967 | 33059580 | Curr Vasc Pharmacol | Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role? | 2021 | Details |
| A05968 | 33058967 | Diabetes Metab | Associations between serum total, free and bioavailable testosterone and non-alcoholic fatty liver disease in community-dwelling middle-aged and elderly women. | 2020 | Details |
| A05969 | 33058854 | Metabolism | Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women. | 2020 | Details |
| A05971 | 33058486 | Pediatr Obes | A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity. | 2020 | Details |
| A05972 | 33057854 | Curr Diab Rep | Tissue-Specific Fructose Metabolism in Obesity and Diabetes. | 2020 | Details |
| A05973 | 33055335 | Wiad Lek | APOPTOTIC PROCESSES' RESEARCH ON THE MODEL OF TYPE 2 DIABETES MELLITUS ON OBESITY'S BACKGROUND UNDER THE INFLUENCE OF DENSE BEAN EXTRACT. | 2020 | Details |
| A05974 | 33055315 | Rom J Intern Med | Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A05975 | 33054645 | Ther Umsch | [Elevated liver function tests - as incidental finding in general practice]. | 2020 | Details |
| A05976 | 33053981 | Zhonghua Gan Zang Bing Za Zhi | [Physical activity intervention for non-alcoholic fatty liver disease in children]. | 2020 | Details |
| A05977 | 33053942 | Clin Mol Hepatol | Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights. | 2020 | Details |
| A05978 | 33053941 | Clin Mol Hepatol | Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease. | 2020 | Details |
| A05979 | 33053934 | Clin Mol Hepatol | Autophagy and liver cancer. | 2020 | Details |
| A05980 | 33053793 | Diagnostics (Basel) | Clinical and Biochemical Predictors of Nonalcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus Patients at Primary Health Care Level in South Western Saudi Arabia. | 2020 | Details |
| A05981 | 33053631 | Nutrients | Microbiota, Fiber, and NAFLD: Is There Any Connection? | 2020 | Details |
| A05982 | 33052552 | Obes Surg | Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan. | 2020 | Details |
| A05983 | 33052067 | Am J Physiol Cell Physiol | Inositol-requiring enzyme 1α links palmitate-induced mTOR activation and lipotoxicity in hepatocytes. | 2020 | Details |
| A05984 | 33051603 | Nat Rev Gastroenterol Hepatol | Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. | 2020 | Details |
| A05985 | 33050862 | Curr Pharm Biotechnol | Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review. | 2022 | Details |
| A05986 | 33050482 | Int J Mol Sci | Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach. | 2020 | Details |
| A05987 | 33050138 | Biomedicines | Tissue-Specific Role of Macrophages in Noninfectious Inflammatory Disorders. | 2020 | Details |
| A05988 | 33050067 | Biomolecules | Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH). | 2020 | Details |
| A05989 | 33050035 | Cells | Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation. | 2020 | Details |
| A05990 | 33049948 | Metabolites | What's Past Is Prologue: History of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05991 | 33049668 | Front Biosci (Landmark Ed) | Current treatment paradigms and emerging therapies for NAFLD/NASH. | 2021 | Details |
| A05992 | 33048844 | J Clin Invest | Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis. | 2021 | Details |
| A05993 | 33047893 | Liver Transpl | Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. | 2020 | Details |
| A05996 | 33046368 | HPB (Oxford) | Estimated functional remnant pancreatic volume predicts nonalcoholic fatty liver disease after pancreaticoduodenectomy: use of computed tomography attenuation value of the pancreas. | 2020 | Details |
| A05997 | 33045675 | J Trace Elem Med Biol | A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. | 2020 | Details |
| A05998 | 33045403 | Contemp Clin Trials | The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. | 2020 | Details |
| A05999 | 33045214 | Life Sci | Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease. | 2020 | Details |
| A06000 | 33042259 | Theranostics | Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development. | 2020 | Details |
| A06001 | 33042108 | Front Immunol | Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. | 2020 | Details |
| A06002 | 33042004 | Front Endocrinol (Lausanne) | Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity. | 2020 | Details |
| A06003 | 33040692 | Trop Doct | Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. | 2020 | Details |
| A06004 | 33040080 | Cell Death Dis | USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638. | 2020 | Details |
| A06005 | 33039693 | Contemp Clin Trials | Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers. | 2020 | Details |
| A06006 | 33039155 | Clin Nutr | Association between blood copper and nonalcoholic fatty liver disease according to sex. | 2020 | Details |
| A06007 | 33038914 | Curr Pediatr Rev | Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A06008 | 33038873 | Pediatr Res | Pediatric obesity-related non-alcoholic fatty liver disease: waist-to-height ratio best anthropometrical predictor. | 2020 | Details |
| A06009 | 33038502 | Contemp Clin Trials | A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study. | 2020 | Details |
| A06010 | 33038434 | J Hepatol | Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. | 2020 | Details |
| A06011 | 33038432 | J Hepatol | Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis. | 2020 | Details |
| A06012 | 33038431 | J Hepatol | Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. | 2020 | Details |
| A06013 | 33037981 | Hepatol Int | Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism. | 2020 | Details |